B-Scada, Inc.

SCDA
About the company

B-Scada, Inc. focuses on the development and commercialization of agentic artificial intelligence software-as-a-service for small- and medium-sized business, corporate clients, and high net worth individuals. Its solutions address operational inefficiencies for human resources, financial planning, inventory management, and data aggregation.

Country: United StatesPrice: $0.30Market Cap: $1.5M

Investment snapshot

24%positive consensus
Scored 1d ago

Positive

4

BUY / PASS

Neutral / negative

2 / 10

NEUTRAL / FAIL

Median fair value

$0.26

-15.0% vs price

Models with upside

2 / 17

Positive margin of safety

Strongest signal

10 of 12 pass — Buffett and Marks object

Key risk

No clean pass — all 13 investors flag at least one valuation criterion

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILFAILFAILFAIL · Rank #2951 (Top 95.3%)PASSFAILPASSFAILPASSFAILFAILFAILPASSNEUTRALFAILFAILNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Margin of SafetyN/AN/AN/A-650.0%N/A+14.3%N/A-233.3%+66.7%-42.9%N/A+0.0%N/AN/AN/AN/AN/A
Financial Basis

Annual history · FY 2015

Latest source filing: 2016-01-28

Score computed: 2026-11-14

Annual history · FY 2015

Latest source filing: 2016-01-28

Score computed: 2026-11-14

Annual history · FY 2015

Latest source filing: 2016-01-28

Score computed: 2026-11-14

Annual history · FY 2015

Latest source filing: 2016-01-28

Score computed: 2026-11-14

Annual history · FY 2015

Latest source filing: 2016-01-28

Score computed: 2026-11-14

Annual history · FY 2015 · Market data at 2026-11-01

Latest source filing: 2016-01-28

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2015

Latest source filing: 2016-01-28

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2015

Latest source filing: 2016-01-28

Score computed: 2026-11-14

Annual history · FY 2015 · Qualitative assessment

Latest source filing: 2016-01-28

Score computed: 2026-11-14

Annual history · FY 2015 · Qualitative assessment

Latest source filing: 2016-01-28

Score computed: 2026-11-14

Annual history · FY 2015 · Market data at 2026-11-01

Latest source filing: 2016-01-28

Score computed: 2026-11-14

Annual history · FY 2015 · Price history 2026-08-01–2026-11-01

Latest source filing: 2016-01-28

Score computed: 2026-11-14

Annual history · FY 2015 · Qualitative assessment

Latest source filing: 2016-01-28

Score computed: 2026-11-14

Annual history · FY 2015 · Price history 2026-08-01–2026-11-01

Latest source filing: 2016-01-28

Score computed: 2026-11-14

Annual history · FY 2015

Latest source filing: 2016-01-28

Score computed: 2026-11-14

Annual history · FY 2015

Latest source filing: 2016-01-28

Score computed: 2026-11-14

Annual history · FY 2015 · Price history 2026-08-01–2026-11-01

Latest source filing: 2016-01-28

Score computed: 2026-11-14

Where It Passes

  • Debt & Leverage83% pass✓ 13✗ 2▾

    10 of 12 pass — Buffett and Marks object

    LT Debt vs Net Current AssetsLT Debt $0.1M vs NCA $0.8M
    ✓GrahamLT Debt <= Net Current Assets
    Debt/Equity & Interest CoverageD/E: 0.04, IC: -97.0x
    ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
    Total Debt / Equity0.04
    ✓Lynch< 0.33
    Cash - Long-term Debt$0.8M
    ✓LynchPositive preferred
    LT Debt / Total Assets Change3.34% -> 3.07%
    ✓PiotroskiDecreased YoY
    Current Assets / Current Liabilities2.81
    ✓Dreman> 1.5✓SchlossCurrent ratio >= 1.50x (app cutoff)
    Total Debt / Shareholders' Equity0.04
    ✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00x
    Debt Levels0.04
    ✓MungerDebt/Equity < 0.5✓AkreDebt/Equity < 0.3
    Interest Coverage & Debt/EBITDAIC=-97.0x, D/EBITDA=N/A
    ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Total Debt / Shareholders Equity0.04
    ✓Ackman<= 1.0
    Negative debt-to-equity (higher means less debt)-0.0450; #977/4210 (top 23.2%)
    ✓AsnessTop 30% of eligible cross-section

Where It Falls Short

  • Valuation0% pass✓ 2✗ 26▾

    No clean pass — all 13 investors flag at least one valuation criterion

    Price / 3-yr avg EPS12.9x
    ✓Graham<= 15x
    Price-to-Book Ratio3.6x
    ✗Graham<= 1.5x
    P/E x P/B46.10
    ✗Graham<= 22.5
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    EBIT / Enterprise Value-77.6%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=-77.6%, ROC=-346.6%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Price / EPS
    ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price / (CFO / Shares)N/A (negative CFPS)
    ✗Dreman< 8x
    Price / Book Value per Share3.6x
    ✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
    Valuation ReasonablenessOE Yield=-4.9%
    ✗MungerP/E < 25 or Owner Earnings Yield > 5%
    P/E or FCF YieldFCF Yield=-4.6%
    ✗PabraiP/E < 15 or FCF Yield > 10%
    P/B or P/E vs. Historical AverageP/B=3.6x
    ✗MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic Value14.3% (IV=$0.35 vs Price=$0.30)
    ✗Marks>= 20% below intrinsic value
    Price / FCF per ShareN/A (negative FCF)
    ✗Ackman<= 25
    Price vs. Trailing Low
    ✗Templeton<= 120% of trailing low (certified split-adjusted live window)
    Net income / market capitalization-27.29%; #4749/6340 (top 74.9%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Positive book equity / market capitalization+1.5609; #872/6449 (top 13.5%)
    ✓AsnessTop 30% of eligible cross-section
    Price / Diluted EPS
    ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E
    ✗Neff> 0.7 (Neff's published traditional edge)
    Price / Tangible Book Value per Share4.16x
    ✗SchlossP/TBV <= 1.00x (app cutoff)
    Book Value per Share Change
    ✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization+1.3263; #1465/5247 (top 27.9%)
    ✗OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization-4.57%; #2948/4519 (top 65.2%)
    ✗OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date
    ✗OshaughnessyTop 10% of eligible cross-section
  • Growth0% pass✓ 3✗ 10▾

    No clean pass — all 8 investors flag at least one growth criterion

    EPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)
    ✗Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue GrowthInv: new vs Rev: -5.0%
    ✗LynchInventory growth < Revenue growth
    EPS Growth Direction$-0.01 (2010) -> $-0.01 (2015)
    ✗DremanPositive over recent years
    EPS CAGR100.0% CAGR over 2 years
    ✓Dreman> 5% annualized
    Positive Net Income Frequency4/6 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth31.7%
    ✓Ackman>= 5%
    Positive EPS Growth Frequency1/3 years with positive EPS growth
    ✗AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trendgross margin 88.3% -> 76.7%, operating margin 31.0% -> -28.9%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR18.6%
    ✓SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
  • Profitability6% pass✓ 5✗ 30▾

    15 of 16 flag SCDA's profitability — Graham, Buffett, Lynch +12 more

    Positive EPS (10 years)3/7 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)
    ✗Graham>= 33% growth
    Net Income Positive (10+ years)4/7 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)43.5%
    ✓Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)-28.9% (latest)
    ✓BuffettStable or rising over 10 years
    Free Cash Flow Proxy$-0.4M
    ✗BuffettPositive and growing
    Earnings Variance (10-yr CoV)1.60
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    ROE-17.5%
    ✗Lynch> 15%
    EBIT / Enterprise Value-77.6%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=-77.6%, ROC=-346.6%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Net Income / Total Assets-14.30%
    ✗PiotroskiROA > 0
    ROA Change YoY33.59% -> -14.30% (delta: -47.90%)
    ✗PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=-1.70%, ROA=-14.30%
    ✓PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY87.9% -> 76.7%
    ✗PiotroskiImproved YoY
    Pre-Tax Income / Revenue-29.1%
    ✗Dreman>= 8%
    Net Income / Shareholders' Equity-17.5%
    ✗Dreman> 12%
    Margin of SafetyP/B=3.6x
    ✗PabraiP/B < 1.5 or P/E < 15
    Return on Equity43.5% (3-yr avg)
    ✓AkreROE > 20% (3-year avg)
    Discount to Intrinsic Value14.3% (IV=$0.35 vs Price=$0.30)
    ✗Marks>= 20% below intrinsic value
    Positive Net Income Frequency4/6 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue-28.9%
    ✗Ackman>= 15%
    Net Income / Shareholders Equity-17.5%
    ✗Ackman>= 15%
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend31.0% (2013) -> -28.9% (2015)
    ✗TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trendgross margin 88.3% -> 76.7%, operating margin 31.0% -> -28.9%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    Net income / market capitalization-27.29%; #4749/6340 (top 74.9%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Gross profit / total assets+53.36%; #593/3702 (top 16.0%)
    ✓AsnessTop 30% of eligible cross-section
    Net income / positive book equity-17.48%; #3635/5226 (top 69.6%)
    ✗AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-0.3053; #4617/5884 (top 78.5%)
    ✗AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
    Positive Diluted-EPS Years3/5 years positive
    ✗Schloss>= 70% positive over 5-10 observed years (app rule)
  • Cash Flow10% pass✓ 2✗ 10▾

    9 of 10 flag SCDA's cash flow — Buffett, Lynch, Piotroski +6 more

    Free Cash Flow Proxy$-0.4M
    ✗BuffettPositive and growing
    FCF Positive and Growing$-0.1M
    ✗LynchPositive and growing
    Operating Cash Flow$-0.0M
    ✗PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=-1.70%, ROA=-14.30%
    ✓PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)N/A (negative CFPS)
    ✗Dreman< 8x
    P/E or FCF YieldFCF Yield=-4.6%
    ✗PabraiP/E < 15 or FCF Yield > 10%
    FCF Positive4/5 years FCF positive
    ✓MarksPositive FCF in majority of recent years
    (OCF - CapEx) / Market Cap-0.8%
    ✗Ackman>= 4%
    Price / FCF per ShareN/A (negative FCF)
    ✗Ackman<= 25
    Positive Operating Cash Flow frequency4/6 years positive
    ✗SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures$-0.1M
    ✗Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization-4.57%; #2948/4519 (top 65.2%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Efficiency25% pass✓ 3✗ 8▾

    6 of 8 flag SCDA's efficiency — Buffett, Greenblatt, Piotroski +3 more

    Current Ratio2.81
    ✓Graham>= 2.0
    ROIC (3-5 yr avg)-1.0%
    ✗Buffett> 10%
    ROIC - WACC-11.0%
    ✗BuffettPositive (WACC = 10%)
    EBIT / (NWC + Net Fixed Assets)-346.6%
    ✗Greenblatt> 25%
    Current Ratio Change YoY5.97 -> 2.81
    ✗PiotroskiIncreased YoY
    Revenue / Total Assets Change YoY0.66x -> 0.70x
    ✓PiotroskiImproved YoY
    Current Assets / Current Liabilities2.81
    ✓Dreman> 1.5
    Return on Invested Capital-18.6%
    ✗Munger> 15%
    ROIC (high and growing)FY2013: ROIC=unavailable; FY2014: ROIC=15.6%; FY2015: ROIC=-18.6%
    ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
    Reinvestment Rate x ROICN/A (non-positive net income)
    ✗AkreReinvestment Rate * ROIC > 10%
    ROIC (5-year)1/2 years above 12% (latest -18.6%)
    ✗SleepROIC > 12% in a majority of years
  • Verdicts27% pass✓ 4✗ 11▾

    Split decision: 10 FAIL · 4 PASS · 2 NEUTRAL

    Overall verdict
    ✗GrahamFAIL (3/9)✗BuffettFAIL (2/9)✗LynchFAIL (2/7)✗GreenblattRank #2951✓PiotroskiPASS (F-Score 4)✗DremanFAIL (3/11)✓MungerPASS (2/4)✗PabraiFAIL (0/3)✓AkrePASS (3/6)✗MarksFAIL (1/5)✗AckmanFAIL (3/9)✗TempletonFAIL (2/8)✓SleepPASS (3/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (1/6)✗SchlossFAIL (2/7)•OshaughnessyNEUTRAL (Not ranked)
  • Valuation models33% pass✓ 2✗ 4▾

    Models split on SCDA at $0.30 — fair values range $0.04–$0.90

    Greenblatt fair value$0.04
    ✗Greenblatt-650.0% margin vs $0.30
    Dreman fair value$0.35
    ✓Dreman+14.3% margin vs $0.30
    Pabrai fair value$0.09
    ✗Pabrai-233.3% margin vs $0.30
    Akre fair value$0.90
    ✓Akre+66.7% margin vs $0.30
    Marks fair value$0.21
    ✗Marks-42.9% margin vs $0.30
    Templeton fair value$0.30
    ✗Templeton0.0% margin vs $0.30

Business & financials

Financial snapshot: annual FY 2015. Current investor scores may use newer quarterly data.

Company Profile

Size: Micro Cap($1.5M)
Revenue: $1.9M-5.0% YoY
Net Income: $-398221.00-138.7% YoY

Financial Snapshot

Operating Margin-28.9%
Return on Equity-17.5%
Debt / Equity0.04
Current Ratio2.81
EPS (Diluted)$-0.01+0.0% 1y
Shares Retired0.0% / −10.8% 2y

Similar Companies

No peer companies found in this industry.

Shareholder Return

Fiscal 2015

Retired 0.0% of shares last year, 10.8% issued over two.

Buybacks
—
Dividends
—

What drove EPS

A buyback raises earnings per share without the company earning more. This splits each year's change into the two.

FY13
300.0% = 471.8% + −30.0%
FY14
0.0% = 18.2% + −15.4%
Earnings Fewer shares More shares

The two parts do not sum exactly to the total — the difference is the cross-term, plus preferred capital where the company has any. It is left visible rather than distributed into the other two.

Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

MetricFY 2015
Sources
  • 10-K · 2016-01-28
FY 2014
Sources
  • 10-K · 2015-01-26
FY 2013
Sources
  • 10-K · 2014-01-28
FY 2012
Sources
  • 10-K · 2014-01-28
FY 2011
Sources
  • 10-K · 2012-01-24
Market Cap$1.5Mcurrent--------
Revenue$1.9M↓5%$2.0M↑32%$1.5M↑45%$1.1M↑9%$980.9K
Operating Income-$559.2K↓203%$541.2K↑13%$479.8K↑182%$170.4K↑203%$56.2K
Net Income-$398.2K↓139%$1.0M↑18%$871.2K↑472%$152.4K↑266%$41.7K
EPS (Diluted)$-0.01↓125%$0.04$0.04↑300%$0.01--
Gross Margin76.7%↓13%87.9%88.3%——
Operating Margin-28.9%↓209%26.6%↓14%31.0%↑95%15.9%↑178%5.7%
ROE-17.5%↓145%39.2%↓64%108.8%↑150%-216.0%↓1055%-18.7%
Total Debt$102.4K↓14%$118.5K--$50.0K$50.0K
Shareholders' Equity$2.3M↓13%$2.6M↑228%$800.7K↑1235%-$70.5K↑68%-$222.9K
Current Ratio2.81↓53%5.97↑186%2.09↑158%0.81↑59%0.51
Debt / Equity0.040.05—-0.71↓216%-0.22
Operating Cash Flow-$47.4K↓123%$205.1K↓51%$422.0K↑219%$132.3K↑181%-$164.0K
Free Cash Flow-$66.7K↓161%$109.8K↓73%$413.4K↑226%$126.7K--

Score history

Historical Score Timeline